IPO - TriSalus Life Sciences, Inc.

Form Type: CORRESP

Filing Date: 2025-04-30

Corporate Action: Ipo

Type: New

Accession Number: 000110465925042803

Filing Summary: TriSalus Life Sciences, Inc. has filed a request with the U.S. Securities and Exchange Commission to accelerate the effective date of its Registration Statement on Form S-3, originally filed on April 25, 2025. The Registrant seeks for the statement to become effective on May 2, 2025, at 4:00 p.m. Eastern Time. The request is made by authorized representative Dylan Kornbluth of Cooley LLP, and the Registrant has asked for prompt oral confirmation of the effectiveness once granted. The document is signed by Mary Szela, the Chief Executive Officer of TriSalus Life Sciences, Inc.